October 22, 2020
Individualized Goal Attainment Scaling as a patient-reported outcome measure for Alzheimer disease and dementia
Ardea Outcomes’ poster presented at ISOQOL 2020 demonstrates the validity and responsiveness of Goal Attainment in dementia and Alzheimer disease drug trials.
Justin Stanley; Sanja Stanojevic, Chere Chapman, Kari Knox, Taylor Dunn, Susan Howlett, Kenneth Rockwood (October 2020); Individualized Goal Attainment Scaling as a patient-reported outcome measure for Alzheimer disease and dementia.